En Es

Industry News

Health Summit to Play Greater Role in Chinese Health Industry

By HospiMedica International staff writers
08 May 2018

Image: The Health Industry Summit 2018 covered the entire industry value chain, including key segments such as medical devices, pharmaceutical production, drug distribution and natural health and nutrition (Photo courtesy of tHIS).The Health Industry Summit (tHIS) 2018 held at the National Exhibition and Convention Center in Shanghai on April 11, 2018, was the largest gathering of healthcare industry professionals in the world with well over 200,000 attendees from more than 150 countries and regions and over 7,000 exhibitors. The fourth edition of tHIS covered an exhibition space of over 350,000 square meters with 160 individual events and conferences being held alongside the main expo.

tHIS 2018 is fast becoming China's solution for promoting technology innovations and academic exchange in the medical healthcare arena. China is the second-largest healthcare market in the world and is one of the most attractive in the world for foreign investors. A recent report from McKinsey & Co. estimates China's healthcare market to grow at an unprecedented CAGR of about 12% from USD 357 billion in 2011 to reach USD 1 trillion by 2020. The growth of the Chinese healthcare market is expected to be driven mainly by the country’s ageing population, rise in incidences of lifestyle related diseases such as diabetes and cancer, and major steps taken by the government to improve the local healthcare infrastructure. Recent regulatory changes by the Chinese government are expected to speed up the approvals of medicines and medical devices, thus easing the process of introducing new treatments to the market.

Additionally, under its “Made in China 2025” plan, the Chinese government is focusing on the development of high-performance devices such as diagnostic imaging equipment, robotic surgery devices, high-end medical consumables, including fully degradable cardiovascular stents, wearable devices, and telemedicine. With local companies increasing their technological capabilities and producing high-end medical devices, China’s medical device market will continue to strengthen even as the competition between the players intensifies.

In line with the call by Chinese President Xi for greater promotion of the country’s health industry at the Boao Forum for Asia, tHIS 2018 covered the entire industry value chain, including key segments such as medical devices, pharmaceutical production, drug distribution and natural health and nutrition. The key events at the four-day summit included China's top medical equipment and pharmaceutical exhibitions CMEF, PHARMCHINA and API China, which showcased cutting-edge technologies such as virtual reality, augmented reality, wearables and artificial intelligence as part of the new Intelligent Health exhibition. The show also highlighted traditional medicine as China's own solutions for treatment and prevention, which runs parallel to modern medicine and drug development.

Various medical device giants such as GE, United Imaging, Siemens, Philips and Mindray as well as major pharmaceutical groups in China including Sinopharm, Shanghai Pharma and CR Pharmaceuticals used the show as a platform to launch more than 600 new products for the global or Asia Pacific markets.

tHIS 218 was hosted by Reed Sinopharm, a joint venture between the world's leading event organizer Reed Exhibitions and China's state-owned medical & pharmaceutical giant Sinopharm. The next edition of the event is scheduled to be held in May 2019 in Shanghai.

Related Links:
Reed Exhibitions

E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

18 Sep 2018
Digital X-ray Market to Reach USD 13 Billion by 2023
The digital X-ray market is expected to grow at a CAGR of 8.5% from USD 8.68 billion in 2018 to USD 13.04 billion by 2023, driven by a growing geriatric population and resultant increase in the incidence of global diseases, favorable regulations and government initiatives & investments, increased advantages of digital X-ray systems, and technological advancements and product development.
Read More
18 Sep 2018
Study Examines How Medical Device Industry Can Increase Success
An aging global population, growing health awareness, and rising income levels in most emerging markets are driving the need and opportunity for high-quality medical device solutions in these regions. However, in order to capture market share in growth regions such as Asia-Pacific (APAC) and Latin America (LATAM), medical device organizations need to align their emerging-market strategies and business models in line with the regulatory and business landscapes prevailing in the target countries and markets.
Read More
12 Sep 2018
Researchers Develop AI Algorithm to Predict Immunotherapy Response
A team of French researchers have designed an algorithm and developed it to analyze Computed Tomography (CT) scan images, establishing for the first time that artificial intelligence (AI) can process medical images to extract biological and clinical information. The researchers have created a so-called radiomic signature, which defines the level of lymphocyte infiltration of a tumor and provides a predictive score for the efficacy of immunotherapy in the patient.
Read More
12 Sep 2018
Fujifilm and IU School of Medicine to Study AI in Diagnostic Imaging
Fujifilm Corporation has entered into a joint research agreement with Indiana University School of Medicine to develop the application of artificial intelligence (AI) in medical imaging diagnostic support systems.
Read More
12 Sep 2018
Global IVD Market to Reach USD 77 Billion by 2023
The worldwide market for in vitro diagnostic tests is estimated at USD 65 billion in 2018 and is expected to grow 4% annually to USD 77.8 billion by 2023, driven by the aging world population and stream of new test innovations, offset by reimbursement cuts globally and slower buying in the mature sectors.
Read More
06 Sep 2018
VR Tool Increases Efficiency of Brain Scan Analysis
Researchers at the Mark and Mary Stevens Neuroimaging and Informatics Institute at the Keck School of Medicine of University of Southern California have designed a virtual reality (VR) tool for correcting errors in brain scan data. The tool named Virtual Brain Segmenter (VBS) transforms a tedious step in the scientific process into an immersive experience and significantly increases the efficiency of brain scan analysis.
Read More
05 Sep 2018
AI System Accurately Detects Lung Cancer in CT Scans
Engineers from the University of Central Florida's Computer Vision Research Center have developed an artificial intelligence (AI) system which can detect tiny specks of lung cancer in CT scans. Radiologists find it difficult to identify such tiny tumors and have an accuracy of 65%, while the AI system has an accuracy of about 95%, according to the engineers.
Read More
03 Sep 2018
American College of Radiology Releases Initial Use Cases in AI Library
The American College of Radiology Data Science Institute has started releasing its first artificial intelligence (AI) use cases in the ACR DSI TOUCH-AI library for generating feedback ahead of the projected release of all of the use cases in the fall.
Read More
03 Sep 2018
Global Radiation Dose Management Market to Reach USD 1.3 Billion by 2026
The global radiation dose management market was valued at USD 143.2 million in 2017 and is projected to register a CAGR of 26.7% from 2018 to 2026 to reach USD 1.36 billion in 2026.
Read More
Copyright © 2000-2018 TradeMed.com. All rights reserved. | Terms And Conditions